Daxiong Xiang - Search Results

Year	Number of Results
2006	2
2007	4
2010	3
2011	1
2012	4
2013	2
2014	2
2015	2
2016	5
2017	8
2018	18
2019	18
2020	13
2021	19
2022	13
2023	4
2024	2

1

Artificial exosomes for translational nanomedicine.

Li YJ, Wu JY, Liu J, Xu W, Qiu X, Huang S, Hu XB, Xiang DX. Li YJ, et al. J Nanobiotechnology. 2021 Aug 12;19(1):242. doi: 10.1186/s12951-021-00986-2. J Nanobiotechnology. 2021. PMID: 34384440 Free PMC article. Review.

2

Ferroptosis in inflammatory arthritis: A promising future.

Chang S, Tang M, Zhang B, Xiang D, Li F. Chang S, et al. Among authors: xiang d. Front Immunol. 2022 Jul 26;13:955069. doi: 10.3389/fimmu.2022.955069. eCollection 2022. Front Immunol. 2022. PMID: 35958605 Free PMC article. Review.

3

Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic/chemo-/immunotherapy.

Li Y, Wu J, Qiu X, Dong S, He J, Liu J, Xu W, Huang S, Hu X, Xiang DX. Li Y, et al. Bioact Mater. 2022 Jun 29;20:548-560. doi: 10.1016/j.bioactmat.2022.05.037. eCollection 2023 Feb. Bioact Mater. 2022. PMID: 35846843 Free PMC article.

4

Drug-induced hyperglycaemia and diabetes: pharmacogenomics perspectives.

Liu MZ, He HY, Luo JQ, He FZ, Chen ZR, Liu YP, Xiang DX, Zhou HH, Zhang W. Liu MZ, et al. Arch Pharm Res. 2018 Jul;41(7):725-736. doi: 10.1007/s12272-018-1039-x. Epub 2018 Jun 1. Arch Pharm Res. 2018. PMID: 29858981 Review.

5

Topical treatments for diabetic neuropathic pain.

Yang XD, Fang PF, Xiang DX, Yang YY. Yang XD, et al. Exp Ther Med. 2019 Mar;17(3):1963-1976. doi: 10.3892/etm.2019.7173. Epub 2019 Jan 15. Exp Ther Med. 2019. PMID: 30783472 Free PMC article. Review.

6

Nonviral delivery systems for antisense oligonucleotide therapeutics.

Huang S, Hao XY, Li YJ, Wu JY, Xiang DX, Luo S. Huang S, et al. Biomater Res. 2022 Sep 30;26(1):49. doi: 10.1186/s40824-022-00292-4. Biomater Res. 2022. PMID: 36180936 Free PMC article. Review.

7

Apoptotic bodies for advanced drug delivery and therapy.

Zhou M, Li YJ, Tang YC, Hao XY, Xu WJ, Xiang DX, Wu JY. Zhou M, et al. J Control Release. 2022 Nov;351:394-406. doi: 10.1016/j.jconrel.2022.09.045. Epub 2022 Sep 27. J Control Release. 2022. PMID: 36167267 Review.

8

Recent progress of macrophage vesicle-based drug delivery systems.

Xu WJ, Cai JX, Li YJ, Wu JY, Xiang D. Xu WJ, et al. Among authors: xiang d. Drug Deliv Transl Res. 2022 Oct;12(10):2287-2302. doi: 10.1007/s13346-021-01110-5. Epub 2022 Jan 4. Drug Deliv Transl Res. 2022. PMID: 34984664 Review.

9

Optimization of polymyxin B regimens for the treatment of carbapenem-resistant organism nosocomial pneumonia: a real-world prospective study.

Tang T, Li Y, Xu P, Zhong Y, Yang M, Ma W, Xiang D, Zhang B, Zhou Y. Tang T, et al. Among authors: xiang d. Crit Care. 2023 Apr 28;27(1):164. doi: 10.1186/s13054-023-04448-z. Crit Care. 2023. PMID: 37106370 Free PMC article.

10

Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer.

Li YJ, Wu JY, Wang JM, Xiang DX. Li YJ, et al. J Control Release. 2020 Apr 10;320:105-111. doi: 10.1016/j.jconrel.2020.01.041. Epub 2020 Jan 21. J Control Release. 2020. PMID: 31978441 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

109 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Results by year